Biology is becoming engineerable

we are investing in a future where bioengineering has industrial scale and speed, and today’s barely conceivable medicines are routine

Ring 1
Ring 2
Ring 3
Ring 4
Ring 1
Ring 2
Ring 3
Ring 4

We partner with innovators

building groundbreaking companies with the following characteristics
dna

Advanced or emerging therapeutic platform

novel biologics, cell therapies, gene therapies, and precision small molecules

treatment

Treating or curing life-threatening diseases

cardiovascular, infectious, neurologic, oncologic, rheumatologic, and other serious diseases

microscope

High-resolution, high-throughput biology

computational drug discovery, novel screening and imaging tools, and multi-omics that accelerate discovery

manufacturing

Designing for manufacturability

appropriate manufacturing at each stage of development

clinical trials

Starting clinical trials

long-term partnerships with companies from pre-IND to commercialization